CAS: 115268-43-4 - (1R,3S,7S,8S,10S,12S,18R)-7-Hydroxy-12-[1(S)-hydroxy-3-[4-methyl-3,6-dihydro-2H-pyran-2(S)-yl]-2(E)-propenyl]-3-methyl-5-methylene-9,13,22-trioxatricyclo[16.3.1.0(8,10)]docosa-15,19-dien-14-one

Formel: C₃₀H₄₂O₇

InChl: InChI=1S/C30H42O7/c1-19-12-13-34-23(15-19)10-11-25(31)27-18-28-30(37-28)26(32)17-21(3)14-20(2)16-24-8-4-6-22(35-24)7-5-9-29(33)36-27/h4-6,9-12,20,22-28,30-32H,3,7-8,13-18H2,1-2H3/b9-5-,11-10+/t20-,22-,23+,24-,25-,26-,27-,28-,30-/m0/s1

InChI Key: InChIKey=MSBQEQDLFWWWMV-XZZGLLCESA-N

SMILES: O=C1OC(CC2OC2C(O)CC(=C)CC(C)CC3OC(C=CC3)CC=C1)C(O)C=CC4OCC=C(C)C4

Synonyme:

• (-)-Laulimalide
• (1R,3S,7S,8S,10S,12S,15Z,18R)-12-[(1S,2E)-3-[(2S)-3,6-Dihydro-4-methyl-2H-pyran-2-yl]-1-hydroxy-2-propen-1-yl]-7-hydroxy-3-methyl-5-methylene-9,13,22-trioxatricyclo[16.3.1.0^8,10]docosa-15,19-dien-14-one
• 9,13,22-Trioxatricyclo[16.3.1.0^8,10]docosa-15,19-dien-14-one, 12-[(1S,2E)-3-[(2S)-3,6-dihydro-4-methyl-2H-pyran-2-yl]-1-hydroxy-2-propen-1-yl]-7-hydroxy-3-methyl-5-methylene-, (1R,3S,7S,8S,10S,12S,15Z,18R)-
• 9,13,22-Trioxatricyclo[16.3.1.0^8,10]docosa-15,19-dien-14-one, 12-[(1S,2E)-3-[(2S)-3,6-dihydro-4-methyl-2H-pyran-2-yl]-1-hydroxy-2-propenyl]-7-hydroxy-3-methyl-5-methylene-, (1R,3S,7S,8S,10S,12S,15Z,18R)-
• 9,13,22-Trioxatricyclo[16.3.1.0^8,10]docosa-15,19-dien-14-one, 12-[3-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-1-hydroxy-2-propenyl]-7-hydroxy-3-methyl-5-methylene-, [1R-[1R*,3S*,7S*,8S*,10S*,12S*[1S*,2E,3(S*)],15Z,18R*]]-
• Er 806782
• Fijianolide B

Laulimalide

CAS: 115268-43-4

Laulimalide is a synthetic compound that has shown potential as an anticancer agent. It inhibits …

• Formel: C₃₀H₄₂O₇
• Reinheit: Min. 95%
• Molekulargewicht: 514.65 g/mol

Laulimalide

CAS: 115268-43-4

Microtubule stabilizer; halts cancer cell growth (IC50: 3-30 nM); arrests cells in prometaphase; prevents bipolar …

• Formel: C₃₀H₄₂O₇
• Farbe und Form: Liquid
• Molekulargewicht: 514.65